Trade TLX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Telix Pharmaceuticals Limited American Depositary Shares (TLX) is trading at US$12.59, up 0.68% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$3.84B. Over the past 52 weeks, TLX has traded between US$6.28 and US$13.11. On Syfe you can trade TLX with $0 commission and add it to your watchlist.
| Previous close | US$12.51 |
|---|---|
| Market cap | US$3.84B |
| P/E ratio | 387.02 |
| 52-week range | US$6.28 – US$13.11 |
| Volume | 187.4K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Telix Pharmaceuticals Limited American Depositary Shares
Telix Pharmaceuticals Ltd. is a biopharmaceutical company, which engages in the development and commercialization of several clinical-stage oncology assets. The firm operates through the following segments: Therapeutics (Tx), Precision Medicine (Px), and Telix Manufacturing Solutions (TMS). The Tx segment focuses on development of targeted radionuclide therapies for urologic and neurologic oncology, and other solid tumors. The Px segment includes provision of diagnostic imaging solutions to market and expanding into new geographies and indications. The TMS segment comprises of costs to operate the firm's facilities and assets. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East and Africa. The company was founded by Andreas Kluge and Christian P. Behrenbruch in November 2015 and is headquartered in North Melbourne, Australia.
Year: 2024
Stay on top of TLX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
